ReviewSeminars in ultrasound, CT, and MR2023
The Current State of Timeliness in the Breast Cancer Diagnosis Journey: Abnormal Screening to Biopsy.
Review in Seminars in ultrasound, CT, and MR, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Risk Factors Associated with Delayed Breast Cancer Diagnoses: What Are We Missing?Journal of general internal medicine · 2026Article
- Modeling Workflow, Operational, and Financial Implications of AI-Enabled Same-Day Diagnostic Follow-Up for Screening Mammograms.Proceedings of SPIE--the International Society for Optical Engineering · 2026Article
- Follow-up after an abnormal screening mammogram: Impact of a pandemic on mobile mammography patients.Journal of clinical imaging science · 2026Article
- Socio-Demographic Inequalities in Diagnostic Delays of Breast Cancer: A Multistage Time-to-Diagnosis Analysis.Current oncology (Toronto, Ont.) · 2025Article
- Social Risks and Nonadherence to Recommended Cancer Screening Among US Adults.JAMA network open · 2025Article
- Negative spillover due to constraints on care delivery: a potential source of bias in pragmatic clinical trials.Trials · 2024Article
- Factors Associated With Timeliness and Equity of Access to Outpatient MRI Examinations.Journal of the American College of Radiology : JACR · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
There are several steps involved in a breast cancer diagnosis, starting from the initial abnormal screening mammogram. Each step from the additional imaging to a biopsy provokes anxiety. Timely attention to these appointments will not only help allay anxiety but also provide better care. While breast facilities routinely audit their performance, currently timeliness is not one of the audit parameters. The role of timeliness as a robust quality tool is gaining attention. In this study, we review the timeline of care at our facility over a 1-year period (October 2021- September 2022) and compare them with those reported by National Quality Measures for Breast Centers (NQMBC). Race, ethnicity, location, and type of facility affect the outcome of care and contribute to delays in providing care. In this manuscript, we outline some of the major factors. Societal guidelines outlining some metrics for timeliness may be a useful first step.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.